Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical Medicine (London, England)|January 2, 2004
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M GaleNature Reviews. Endocrinology|November 25, 2010
Therapy: The second time as farce: rosiglitazone and the regulatorsEdwin A M GaleDiabetes Care|May 23, 2015
Smoke or fire? Acute pancreatitis and the liraglutide trialsEdwin A M GaleTransplantation|May 25, 2005
Survival of the fittest? Natural selection in islet transplantationRichard M Smith, Edwin A M GaleDiabetic Medicine : a Journal of the British Diabetic Association|August 25, 2021
Winner's curse: The sad aftermath of the discovery of insulinJames R Wright, Edwin A M GaleDiabetes Care|October 26, 2007
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)Polly J Bingley, Jeffrey L Mahon, Edwin A M Gale, et al.Diabetes|January 5, 2002
High familial risk and genetic susceptibility in early onset childhood diabetesKathleen M Gillespie, Edwin A M Gale, Polly J BingleyBMJ (Clinical Research Ed.)|July 3, 2015
Productivity of authors in the field of diabetes: bibliographic analysis of trial publicationsFrits Holleman, Mick Uijldert, Lennart F Donswijk, et al.Diabetes Care|May 7, 2013
A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?Peter C Butler, Michael Elashoff, Robert Elashoff, et al.Pageof 2